850374-94-6 Usage
Uses
Used in Organic Synthesis:
1-(TERT-BUTYL) 6-METHYL 3-IODO-1H-INDOLE-1,6-DICARBOXYLATE is used as a key intermediate in organic synthesis for the creation of various biologically active molecules. Its presence of multiple functional groups allows for a wide range of chemical reactions, making it a valuable component in the synthesis of complex organic compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 1-(TERT-BUTYL) 6-METHYL 3-IODO-1H-INDOLE-1,6-DICARBOXYLATE is utilized as a starting material or a building block in the development of new drug compounds. Its unique structure and properties contribute to the design and synthesis of potential therapeutic agents, particularly those targeting specific biological pathways or receptors.
Used in Drug Development:
1-(TERT-BUTYL) 6-METHYL 3-IODO-1H-INDOLE-1,6-DICARBOXYLATE is employed in drug development as a precursor for the synthesis of pharmaceuticals with potential therapeutic applications. Its versatility in chemical reactions and compatibility with various synthetic routes make it an essential component in the creation of novel drug candidates.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-(TERT-BUTYL) 6-METHYL 3-IODO-1H-INDOLE-1,6-DICARBOXYLATE is used as a structural element in the design of new molecules with potential medicinal properties. Its presence in the final compounds can influence their pharmacokinetics, pharmacodynamics, and overall therapeutic efficacy.
Overall, 1-(TERT-BUTYL) 6-METHYL 3-IODO-1H-INDOLE-1,6-DICARBOXYLATE is a multifaceted chemical compound with applications spanning across various scientific disciplines, particularly in the realms of organic synthesis, pharmaceutical research, drug development, and medicinal chemistry. Its unique structural features and functional groups make it a promising candidate for the creation of innovative and effective therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 850374-94-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,0,3,7 and 4 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 850374-94:
(8*8)+(7*5)+(6*0)+(5*3)+(4*7)+(3*4)+(2*9)+(1*4)=176
176 % 10 = 6
So 850374-94-6 is a valid CAS Registry Number.
InChI:InChI=1/C15H16INO4/c1-15(2,3)21-14(19)17-8-11(16)10-6-5-9(7-12(10)17)13(18)20-4/h5-8H,1-4H3
850374-94-6Relevant articles and documents
five Yuan fragrance heterocyclic structure containing the anti-hepatitis c compound and its preparation and use
-
, (2016/11/21)
The invention discloses an anti-HCV (hepatitis C) compound containing a five-membered heteroaromatic ring structure, as well as a preparation method and applications thereof. The compound has a structure shown as the formula I, the compound has excellent anti-HCV virus activity, can be used for preparing anti-HCV drugs, the prepared drugs can be applied by adopting oral administration, intravenous injection or intramuscular injection.
Catalytic anomeric aminoalkynylation of unprotected aldoses
Kimura, Yasuaki,Ito, Soichi,Shimizu, Yohei,Kanai, Motomu
, p. 4130 - 4133 (2013/09/12)
A copper(I)-catalyzed anomeric aminoalkynylation reaction of unprotected aldoses was realized. Use of an electron-deficient phosphine ligand, boric acid to stabilize the iminium intermediate, and a protic additive (IPA) to presumably enhance reversible carbohydrate-boron complexation were all essential for efficient conversion. The reaction proceeded well even with a natural disaccharide substrate, suggesting that the developed catalytic reaction could be useful for the synthesis of glycoconjugates with minimum use of protecting groups.
Amino-zinc-ene-enolate cyclization: A short access to cis-3-substituted prolino-homotryptophane derivatives
Mothes, Celine,Lavielle, Solange,Karoyan, Philippe
, p. 6706 - 6710 (2008/12/22)
(Chemical Equation Presented) Proline chimeras are useful tools for medicinal chemistry and/or biological applications. The asymmetric synthesis of cis-3-substituted prolines can be easily achieved via amino-zinc-ene-enolate cyclization followed by transm
